27 apr 2017 anni - FDA held an expert roundtable for healthcare professionals to discuss their experiences with the use of cough suppressants in children (<18 years of age), particularly opioid containing antitussive products, as well as the data available to support recommendations made by various professional societies regarding the treatment of cough in children.

Aggiunto al nastro di tempo:

Opioids and the FDA

ByAnastasia

13 nov 2018

0 0 333

Data: